Thanks. Ah, I thought it was higher, but 8% isn't bad. Does that mean 8% of the market is potentially cut out of the equation and not the 50% I mistakenly assumed in my initial question?
Also, b/c WHO redefined GBM, does that mean the FDA uses the same definition?